Loading…

Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). Retrospective cohort study. A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment (SRD) were included from May 2...

Full description

Saved in:
Bibliographic Details
Published in:Ophthalmology science (Online) 2022-06, Vol.2 (2), p.100152, Article 100152
Main Authors: Aisu, Nao, Miyake, Masahiro, Hosoda, Yoshikatsu, Mori, Yuki, Takahashi, Ayako, Muraoka, Yuki, Ueda-Arakawa, Naoko, Miyata, Manabu, Oishi, Akio, Tamura, Hiroshi, Ooto, Sotaro, Yamashiro, Kenji, Tsujikawa, Akitaka
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2992-87787c4150ba6b7804ce9aa799a09524190c7d0168a393549e58b2ab9b7dbbae3
cites cdi_FETCH-LOGICAL-c2992-87787c4150ba6b7804ce9aa799a09524190c7d0168a393549e58b2ab9b7dbbae3
container_end_page
container_issue 2
container_start_page 100152
container_title Ophthalmology science (Online)
container_volume 2
creator Aisu, Nao
Miyake, Masahiro
Hosoda, Yoshikatsu
Mori, Yuki
Takahashi, Ayako
Muraoka, Yuki
Ueda-Arakawa, Naoko
Miyata, Manabu
Oishi, Akio
Tamura, Hiroshi
Ooto, Sotaro
Yamashiro, Kenji
Tsujikawa, Akitaka
description To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). Retrospective cohort study. A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment (SRD) were included from May 2007 to June 2017 and followed up for at least 2 years. Patients who underwent ocular treatment other than cataract surgery before the beginning of recruitment and those who had macular neovascularization at baseline were excluded. All patients underwent a comprehensive ophthalmic evaluation, including measurements of best-corrected visual acuity (BCVA), slit-lamp examination, dilated fundus examination, color fundus photography, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and spectral-domain OCT. An inverse probability of treatment weighting (IPTW) methodology was applied to balance 18 baseline characteristics between patients who received rf-PDT (rf-PDT group) and those who did not receive treatment (controls). Inverse probability of treatment weighting survival analysis and regression were performed. The proportion of patients whose BCVA at 24 months was the same or improved compared with the baseline visual acuity (VA) (VA maintenance rate). A total of 155 eyes (rf-PDT group: 74; controls: 81) were analyzed. The patients’ backgrounds were well balanced after IPTW with standardized differences of < 0.10. An IPTW regression analysis revealed that the VA maintenance rate was significantly higher in the rf-PDT group than in the controls (93.6% vs. 70.9%, P 
doi_str_mv 10.1016/j.xops.2022.100152
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0364a8b9f26d4be0bd97e53fff4cbff3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2666914522000410</els_id><doaj_id>oai_doaj_org_article_0364a8b9f26d4be0bd97e53fff4cbff3</doaj_id><sourcerecordid>S2666914522000410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2992-87787c4150ba6b7804ce9aa799a09524190c7d0168a393549e58b2ab9b7dbbae3</originalsourceid><addsrcrecordid>eNp9kM1KAzEUhQdRsGhfwNW8wNQk8xtwI6VqoaBoXYeb5MZmaCdDMi327c1YEVeu7uXAOZzzJckNJTNKaHXbzj5dH2aMMBYFQkt2lkxYVVUZp0V5_ue_TKYhtIQQVtKcFXSSyIUxqAZ7wA5DSJ1JX1HvFerMbPfYKUxfNm5w-tjBzqp0vUEP_TE1zqfzjXdd1ObYDR626Rt6tw9Rdt46j4PtXA_D5nidXBjYBpz-3Kvk_WGxnj9lq-fH5fx-lSnGOcuaum5qVdCSSKhk3ZBCIQeoOQfCy1iWE1XruLeBnOdlwbFsJAPJZa2lBMyvkuUpVztoRe_tDvxROLDiW3D-Q4AfrNqiIHlVQCO5YZUuJBKpeY1lbowplDQmj1nslKW8C8Gj-c2jRIzQRStG6GKELk7Qo-nuZMK48mDRi6DsyFBbHxnHGvY_-xcf-oxg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy</title><source>PMC (PubMed Central)</source><source>ScienceDirect Journals</source><creator>Aisu, Nao ; Miyake, Masahiro ; Hosoda, Yoshikatsu ; Mori, Yuki ; Takahashi, Ayako ; Muraoka, Yuki ; Ueda-Arakawa, Naoko ; Miyata, Manabu ; Oishi, Akio ; Tamura, Hiroshi ; Ooto, Sotaro ; Yamashiro, Kenji ; Tsujikawa, Akitaka</creator><creatorcontrib>Aisu, Nao ; Miyake, Masahiro ; Hosoda, Yoshikatsu ; Mori, Yuki ; Takahashi, Ayako ; Muraoka, Yuki ; Ueda-Arakawa, Naoko ; Miyata, Manabu ; Oishi, Akio ; Tamura, Hiroshi ; Ooto, Sotaro ; Yamashiro, Kenji ; Tsujikawa, Akitaka</creatorcontrib><description>To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). Retrospective cohort study. A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment (SRD) were included from May 2007 to June 2017 and followed up for at least 2 years. Patients who underwent ocular treatment other than cataract surgery before the beginning of recruitment and those who had macular neovascularization at baseline were excluded. All patients underwent a comprehensive ophthalmic evaluation, including measurements of best-corrected visual acuity (BCVA), slit-lamp examination, dilated fundus examination, color fundus photography, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and spectral-domain OCT. An inverse probability of treatment weighting (IPTW) methodology was applied to balance 18 baseline characteristics between patients who received rf-PDT (rf-PDT group) and those who did not receive treatment (controls). Inverse probability of treatment weighting survival analysis and regression were performed. The proportion of patients whose BCVA at 24 months was the same or improved compared with the baseline visual acuity (VA) (VA maintenance rate). A total of 155 eyes (rf-PDT group: 74; controls: 81) were analyzed. The patients’ backgrounds were well balanced after IPTW with standardized differences of &lt; 0.10. An IPTW regression analysis revealed that the VA maintenance rate was significantly higher in the rf-PDT group than in the controls (93.6% vs. 70.9%, P &lt; 0.001, 12 months; 85.7% vs. 69.8%, P = 0.019, 24 months). The rf-PDT group tended to show better VA improvement, but was not statistically significant (–0.06 vs. –0.008, P = 0.07, 12 months; –0.06 vs. –0.03, P = 0.32, 24 months). An IPTW Cox regression showed a significantly higher rate of complete SRD remission in the rf-PDT group (hazard ratio, 5.05; 95% confidence interval, 3.24–7.89; P &lt; 0.001). The study suggests the beneficial effect of rf-PDT for cCSC for both VA maintenance and higher proportion of complete SRD remission in the clinical setting.</description><identifier>ISSN: 2666-9145</identifier><identifier>EISSN: 2666-9145</identifier><identifier>DOI: 10.1016/j.xops.2022.100152</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Central serous chorioretinopathy ; Propensity score ; Reduced-fluence photodynamic therapy ; Serous retinal detachment</subject><ispartof>Ophthalmology science (Online), 2022-06, Vol.2 (2), p.100152, Article 100152</ispartof><rights>2022 American Academy of Ophthalmology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2992-87787c4150ba6b7804ce9aa799a09524190c7d0168a393549e58b2ab9b7dbbae3</citedby><cites>FETCH-LOGICAL-c2992-87787c4150ba6b7804ce9aa799a09524190c7d0168a393549e58b2ab9b7dbbae3</cites><orcidid>0000-0001-7410-3764 ; 0000-0002-7740-2732 ; 0000-0001-7603-9954 ; 0000-0002-7574-1749 ; 0000-0002-8195-6287 ; 0000-0002-0977-9458 ; 0000-0001-9354-8558</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2666914522000410$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45779</link.rule.ids></links><search><creatorcontrib>Aisu, Nao</creatorcontrib><creatorcontrib>Miyake, Masahiro</creatorcontrib><creatorcontrib>Hosoda, Yoshikatsu</creatorcontrib><creatorcontrib>Mori, Yuki</creatorcontrib><creatorcontrib>Takahashi, Ayako</creatorcontrib><creatorcontrib>Muraoka, Yuki</creatorcontrib><creatorcontrib>Ueda-Arakawa, Naoko</creatorcontrib><creatorcontrib>Miyata, Manabu</creatorcontrib><creatorcontrib>Oishi, Akio</creatorcontrib><creatorcontrib>Tamura, Hiroshi</creatorcontrib><creatorcontrib>Ooto, Sotaro</creatorcontrib><creatorcontrib>Yamashiro, Kenji</creatorcontrib><creatorcontrib>Tsujikawa, Akitaka</creatorcontrib><title>Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy</title><title>Ophthalmology science (Online)</title><description>To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). Retrospective cohort study. A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment (SRD) were included from May 2007 to June 2017 and followed up for at least 2 years. Patients who underwent ocular treatment other than cataract surgery before the beginning of recruitment and those who had macular neovascularization at baseline were excluded. All patients underwent a comprehensive ophthalmic evaluation, including measurements of best-corrected visual acuity (BCVA), slit-lamp examination, dilated fundus examination, color fundus photography, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and spectral-domain OCT. An inverse probability of treatment weighting (IPTW) methodology was applied to balance 18 baseline characteristics between patients who received rf-PDT (rf-PDT group) and those who did not receive treatment (controls). Inverse probability of treatment weighting survival analysis and regression were performed. The proportion of patients whose BCVA at 24 months was the same or improved compared with the baseline visual acuity (VA) (VA maintenance rate). A total of 155 eyes (rf-PDT group: 74; controls: 81) were analyzed. The patients’ backgrounds were well balanced after IPTW with standardized differences of &lt; 0.10. An IPTW regression analysis revealed that the VA maintenance rate was significantly higher in the rf-PDT group than in the controls (93.6% vs. 70.9%, P &lt; 0.001, 12 months; 85.7% vs. 69.8%, P = 0.019, 24 months). The rf-PDT group tended to show better VA improvement, but was not statistically significant (–0.06 vs. –0.008, P = 0.07, 12 months; –0.06 vs. –0.03, P = 0.32, 24 months). An IPTW Cox regression showed a significantly higher rate of complete SRD remission in the rf-PDT group (hazard ratio, 5.05; 95% confidence interval, 3.24–7.89; P &lt; 0.001). The study suggests the beneficial effect of rf-PDT for cCSC for both VA maintenance and higher proportion of complete SRD remission in the clinical setting.</description><subject>Central serous chorioretinopathy</subject><subject>Propensity score</subject><subject>Reduced-fluence photodynamic therapy</subject><subject>Serous retinal detachment</subject><issn>2666-9145</issn><issn>2666-9145</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kM1KAzEUhQdRsGhfwNW8wNQk8xtwI6VqoaBoXYeb5MZmaCdDMi327c1YEVeu7uXAOZzzJckNJTNKaHXbzj5dH2aMMBYFQkt2lkxYVVUZp0V5_ue_TKYhtIQQVtKcFXSSyIUxqAZ7wA5DSJ1JX1HvFerMbPfYKUxfNm5w-tjBzqp0vUEP_TE1zqfzjXdd1ObYDR626Rt6tw9Rdt46j4PtXA_D5nidXBjYBpz-3Kvk_WGxnj9lq-fH5fx-lSnGOcuaum5qVdCSSKhk3ZBCIQeoOQfCy1iWE1XruLeBnOdlwbFsJAPJZa2lBMyvkuUpVztoRe_tDvxROLDiW3D-Q4AfrNqiIHlVQCO5YZUuJBKpeY1lbowplDQmj1nslKW8C8Gj-c2jRIzQRStG6GKELk7Qo-nuZMK48mDRi6DsyFBbHxnHGvY_-xcf-oxg</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Aisu, Nao</creator><creator>Miyake, Masahiro</creator><creator>Hosoda, Yoshikatsu</creator><creator>Mori, Yuki</creator><creator>Takahashi, Ayako</creator><creator>Muraoka, Yuki</creator><creator>Ueda-Arakawa, Naoko</creator><creator>Miyata, Manabu</creator><creator>Oishi, Akio</creator><creator>Tamura, Hiroshi</creator><creator>Ooto, Sotaro</creator><creator>Yamashiro, Kenji</creator><creator>Tsujikawa, Akitaka</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7410-3764</orcidid><orcidid>https://orcid.org/0000-0002-7740-2732</orcidid><orcidid>https://orcid.org/0000-0001-7603-9954</orcidid><orcidid>https://orcid.org/0000-0002-7574-1749</orcidid><orcidid>https://orcid.org/0000-0002-8195-6287</orcidid><orcidid>https://orcid.org/0000-0002-0977-9458</orcidid><orcidid>https://orcid.org/0000-0001-9354-8558</orcidid></search><sort><creationdate>202206</creationdate><title>Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy</title><author>Aisu, Nao ; Miyake, Masahiro ; Hosoda, Yoshikatsu ; Mori, Yuki ; Takahashi, Ayako ; Muraoka, Yuki ; Ueda-Arakawa, Naoko ; Miyata, Manabu ; Oishi, Akio ; Tamura, Hiroshi ; Ooto, Sotaro ; Yamashiro, Kenji ; Tsujikawa, Akitaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2992-87787c4150ba6b7804ce9aa799a09524190c7d0168a393549e58b2ab9b7dbbae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Central serous chorioretinopathy</topic><topic>Propensity score</topic><topic>Reduced-fluence photodynamic therapy</topic><topic>Serous retinal detachment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aisu, Nao</creatorcontrib><creatorcontrib>Miyake, Masahiro</creatorcontrib><creatorcontrib>Hosoda, Yoshikatsu</creatorcontrib><creatorcontrib>Mori, Yuki</creatorcontrib><creatorcontrib>Takahashi, Ayako</creatorcontrib><creatorcontrib>Muraoka, Yuki</creatorcontrib><creatorcontrib>Ueda-Arakawa, Naoko</creatorcontrib><creatorcontrib>Miyata, Manabu</creatorcontrib><creatorcontrib>Oishi, Akio</creatorcontrib><creatorcontrib>Tamura, Hiroshi</creatorcontrib><creatorcontrib>Ooto, Sotaro</creatorcontrib><creatorcontrib>Yamashiro, Kenji</creatorcontrib><creatorcontrib>Tsujikawa, Akitaka</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Ophthalmology science (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aisu, Nao</au><au>Miyake, Masahiro</au><au>Hosoda, Yoshikatsu</au><au>Mori, Yuki</au><au>Takahashi, Ayako</au><au>Muraoka, Yuki</au><au>Ueda-Arakawa, Naoko</au><au>Miyata, Manabu</au><au>Oishi, Akio</au><au>Tamura, Hiroshi</au><au>Ooto, Sotaro</au><au>Yamashiro, Kenji</au><au>Tsujikawa, Akitaka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy</atitle><jtitle>Ophthalmology science (Online)</jtitle><date>2022-06</date><risdate>2022</risdate><volume>2</volume><issue>2</issue><spage>100152</spage><pages>100152-</pages><artnum>100152</artnum><issn>2666-9145</issn><eissn>2666-9145</eissn><abstract>To investigate the 2-year effectiveness of reduced-fluence photodynamic therapy (rf-PDT) for chronic central serous chorioretinopathy (cCSC). Retrospective cohort study. A total of 223 consecutive patients with newly diagnosed cCSC with active serous retinal detachment (SRD) were included from May 2007 to June 2017 and followed up for at least 2 years. Patients who underwent ocular treatment other than cataract surgery before the beginning of recruitment and those who had macular neovascularization at baseline were excluded. All patients underwent a comprehensive ophthalmic evaluation, including measurements of best-corrected visual acuity (BCVA), slit-lamp examination, dilated fundus examination, color fundus photography, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, and spectral-domain OCT. An inverse probability of treatment weighting (IPTW) methodology was applied to balance 18 baseline characteristics between patients who received rf-PDT (rf-PDT group) and those who did not receive treatment (controls). Inverse probability of treatment weighting survival analysis and regression were performed. The proportion of patients whose BCVA at 24 months was the same or improved compared with the baseline visual acuity (VA) (VA maintenance rate). A total of 155 eyes (rf-PDT group: 74; controls: 81) were analyzed. The patients’ backgrounds were well balanced after IPTW with standardized differences of &lt; 0.10. An IPTW regression analysis revealed that the VA maintenance rate was significantly higher in the rf-PDT group than in the controls (93.6% vs. 70.9%, P &lt; 0.001, 12 months; 85.7% vs. 69.8%, P = 0.019, 24 months). The rf-PDT group tended to show better VA improvement, but was not statistically significant (–0.06 vs. –0.008, P = 0.07, 12 months; –0.06 vs. –0.03, P = 0.32, 24 months). An IPTW Cox regression showed a significantly higher rate of complete SRD remission in the rf-PDT group (hazard ratio, 5.05; 95% confidence interval, 3.24–7.89; P &lt; 0.001). The study suggests the beneficial effect of rf-PDT for cCSC for both VA maintenance and higher proportion of complete SRD remission in the clinical setting.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.xops.2022.100152</doi><orcidid>https://orcid.org/0000-0001-7410-3764</orcidid><orcidid>https://orcid.org/0000-0002-7740-2732</orcidid><orcidid>https://orcid.org/0000-0001-7603-9954</orcidid><orcidid>https://orcid.org/0000-0002-7574-1749</orcidid><orcidid>https://orcid.org/0000-0002-8195-6287</orcidid><orcidid>https://orcid.org/0000-0002-0977-9458</orcidid><orcidid>https://orcid.org/0000-0001-9354-8558</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2666-9145
ispartof Ophthalmology science (Online), 2022-06, Vol.2 (2), p.100152, Article 100152
issn 2666-9145
2666-9145
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0364a8b9f26d4be0bd97e53fff4cbff3
source PMC (PubMed Central); ScienceDirect Journals
subjects Central serous chorioretinopathy
Propensity score
Reduced-fluence photodynamic therapy
Serous retinal detachment
title Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A49%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20Reduced-fluence%20Photodynamic%20Therapy%20for%20Chronic%20Central%20Serous%20Chorioretinopathy&rft.jtitle=Ophthalmology%20science%20(Online)&rft.au=Aisu,%20Nao&rft.date=2022-06&rft.volume=2&rft.issue=2&rft.spage=100152&rft.pages=100152-&rft.artnum=100152&rft.issn=2666-9145&rft.eissn=2666-9145&rft_id=info:doi/10.1016/j.xops.2022.100152&rft_dat=%3Celsevier_doaj_%3ES2666914522000410%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2992-87787c4150ba6b7804ce9aa799a09524190c7d0168a393549e58b2ab9b7dbbae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true